# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2090525 | F | Cytotoxicity against human AU565 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
2. | ALA1815701 | F | Growth inhibition of human AU565 cells at 25 uM after 48 hrs by WST1 assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
3. | ALA1815702 | F | Cytotoxicity against human AU565 cells at 25 uM after 48 hrs by WST1 assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
4. | ALA1828320 | F | Antiproliferative activity against human AU565 after 48 hrs by spectrophotometry | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
5. | ALA1679307 | F | Antiproliferative activity against human AU565 cells after 72 hrs | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
6. | ALA991488 | F | Cytotoxicity against human AU565 cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
7. | ALA982563 | F | Cytotoxicity against human AU565 cells expressing HER2 at 200 nM assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
8. | ALA1115495 | F | Cytotoxicity against human AU565 cells after 48 hrs by MTT assay | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
9. | ALA2363744 | F | SANGER: Inhibition of human AU565 cell growth in a cell viability assay. | Homo sapiens | 98 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
10. | ALA2447104 | F | Ratio of vinblastine IC50 to compound IC50 for human AU565 cells by MTS assay | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
11. | ALA2447120 | F | Growth inhibition of human AU565 cells after 72 hrs by MTS assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
12. | ALA3123700 | F | Cytotoxicity against ER-negative, HER2-positive human AU565 cells after 48 hrs by WST-1 assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
13. | ALA3123701 | F | Growth inhibition of ER-negative, HER2-positive human AU565 cells at >5 uM after 48 hrs by WST-1 assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA3123702 | F | Total growth inhibition of ER-negative, HER2-positive human AU565 cells at >15 uM after 48 hrs by WST-1 assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
15. | ALA3123703 | F | Growth inhibition of ER-negative, HER2-positive human AU565 cells after 48 hrs by WST-1 assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA3296820 | F | Anticancer against human ER-negative AU565 cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
17. | ALA4050178 | F | Antiproliferative activity against human AU565 cells assessed as reduction in cell viability after 5 to 7 days by CellTiter 96 aqueous solution assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
18. | ALA4266307 | F | Antiproliferation activity against human AU565 cells assessed as inhibition of cell proliferation | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
19. | ALA4718832 | F | Antiproliferative activity against human AU565 cells incubated for 72 hrs by ATPlite luminescence assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
20. | ALA4724281 | F | Antiproliferative activity against human AU565 cells assessed as reduction in cell viability incubated for 72 hrs by WST8 assay | Homo sapiens | 28 | cell-based format | Scientific Literature |